Proton Therapy Mediates Dose Reductions to Brain Structures Associated with Cognition in Children with Medulloblastoma.
13/11/2023
/
Publications
/
Dosimetry
This study evaluated dosimetric and cognitive data from 75 patients with medulloblastoma treated with proton (n=36) and photon (n=39). Significant dose...
Proton and Heavy Particle Intracranial Radiosurgery.
13/01/2021
/
Publications
This review provides a comprehensive overview of clinical evidence in the use of particle therapy-based radiosurgery. The vast majority of available data are...
Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
13/01/2021
/
Publications
/
Proton Reirradiation
This study reported the outcomes of 24 patients with leptomeningeal metastases (LM) treated with proton craniospinal irradiation (CSI). With the median follow...
Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy.
13/05/2021
/
Publications
/
Survival
77 patients (38 proton and 39 photon) were evaluated with a median follow-up time of 2.2 years. This study reported no significant differences in symptomatic...
Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
13/07/2021
/
Publications
/
Toxicity
Survival
Twenty adults with medulloblastoma (≥ 22 years old) received postoperative proton CSI. This study reported no acute ≥ grade 3 gastrointestinal or hematologic...
Outcome after Radiotherapy for Vestibular Schwannomas – Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy.
13/04/2022
/
Publications
/
Hypofractionation
Quality of life
Based on the data of 261 patients with VS treated with stereotactic radiosurgery/hypofractionated stereotactic radiotherapy (SRS/HFSRT), this study reported at...
Proton therapy for adult craniopharyngioma: Experience of a single institution in 91 consecutive patients.
14/04/2023
/
Publications
/
Toxicity
This study presented the treatment results of 91 patients with craniopharyngioma received proton therapy after tumor resection (88 patients, 97%), as an...
Proton Radiotherapy for Skull-Base Malignancies: Imaging Considerations of Radiotherapy and Complications.
14/08/2023
/
Publications
/
Imaging System
Toxicity
This article summarized data of PRT for benign and malignant skull-base tumors including pituitary adenomas, craniopharyngiomas, benign meningiomas, vestibular...
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
14/05/2023
/
Publications
This study reported outcomes of 194 patients diagnosed with IDH-mutated WHO grade 2 (n = 128) and WHO grade 3 (n = 66) glioma treated with proton radiation...
Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center.
14/05/2023
/
Publications
/
Proton therapy center
This study presented results of 52 patients with IDH-mutant diffuse gliomas treated with proton radiation. Tumor classified by WHO grade 2, 3 and 4 were 22, 25...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.